Welcome to our dedicated page for Accelerant Holdings SEC filings (Ticker: ARX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accelerant Holdings (NYSE: ARX) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Accelerant is incorporated in the Cayman Islands and its Class A common shares are registered under Section 12(b) of the Exchange Act, trading on the New York Stock Exchange under the symbol ARX.
As a public company and emerging growth company, Accelerant files current reports on Form 8-K to announce material events, including the release of quarterly earnings results and the availability of earnings presentations. These 8-K filings often include or reference press releases that detail Exchange Written Premium, total revenues, net income or loss, Adjusted EBITDA, Adjusted Net Income and other key performance metrics for the specialty insurance risk exchange platform.
Investors can also use this page to locate periodic reports such as Forms 10-Q and 10-K once filed, which are expected to provide more extensive information on Accelerant’s financial statements, risk factors, business description and management’s discussion and analysis. The company has indicated that it files its Form 10-Q within the timelines applicable to a non-accelerated filer and emerging growth company.
In addition, the filings page is a resource for tracking capital markets and corporate structure disclosures, including the registration statement on Form S-1 that supported Accelerant’s initial public offering and the listing of its Class A common shares on the NYSE. Over time, users can review how Accelerant reports on its fee-based revenue model, the composition of Exchange Written Premium, the use of non-GAAP financial measures and items such as profit interest distribution expenses, share-based compensation and foreign currency effects.
Stock Titan enhances these documents with AI-powered summaries that highlight the main points of lengthy filings, helping readers quickly understand the significance of each report while still allowing full access to the underlying SEC documents for detailed review.
Accelerant Holdings (ARX) – Insider Ownership Update
COO Matthew David Sternberg filed an amended Form 3 reporting one derivative position: an employee stock option covering 884,464 Class A shares at an exercise price of $19.31. Twenty-five percent vested after one year; the remaining 75 % vest in 6.25 % quarterly tranches over the next three years. The option expires 09/01/2033. The amendment corrects the 07/23/2025 filing, which overstated the share count by one share and understated the exercise price by $0.01. No non-derivative holdings were disclosed, and the filing does not alter share count, dilution, or cash flow for existing investors.
Accelerant Holdings (ARX) – Form 3/A: Director Paul Christopher Little discloses ownership of a single stock-option grant covering 165,831 Class A shares with a $19.31 exercise price. Twenty-five percent vests after one year; the remaining 75% vests in 6.25% quarterly installments over the next three years, contingent on continued service. This amendment corrects the prior Form 3 filed 23 Jul 2025, reducing the option by one share and increasing the exercise price by $0.01. No other equity positions or material changes are reported.
Accelerant Holdings (ARX) Form 4 filing: Co-founder & CEO Jeffrey L. Radke was granted 8,279,552 stock options on 23 Jul 2025 at an exercise price of $21 per Class A common share. The options expire on 23 Jul 2035.
Vesting schedule: 25 % vests on 23 Jul 2026; the remaining 75 % vests in 6.25 % quarterly tranches through 23 Jul 2029, subject to continuous service. Following the grant, Radke beneficially owns the full 8.28 M derivative securities directly.
Take-aways for investors: the award is sizable and represents future dilution if exercised, but it strengthens management-shareholder alignment and serves as a long-term retention incentive for the CEO.
On 07/23/2025, Co-Founder & Chief Underwriting Officer Francis James O’Neill received a stock option covering 882,611 Class A common shares of Accelerant Holdings (ARX) at an exercise price of $21, as disclosed in a Form 4 filed 07/25/2025.
Vesting terms tie the award to long-term service: 25% vests on 07/23/2026 and the remaining 75% vests in 6.25% quarterly installments through 07/23/2029. The award is coded “A,” indicating a grant with no cash payment or share sale. O’Neill now beneficially owns 882,611 derivative securities, all held directly.
The grant increases potential dilution if exercised but aligns executive compensation with future share-price performance by requiring four years of continued service before full vesting.
Accelerant Holdings (ARX) filed a Form 4 indicating that Co-Founder, Director and Head of Distribution Christopher Lee-Smith received a new stock-option grant on 23 Jul 2025. The option allows him to purchase 2,746,261 Class A common shares at an exercise price of $21 and was reported on 25 Jul 2025.
Vesting terms are service-based: 25 % vests on 23 Jul 2026 (one-year cliff) and the remaining 75 % vests in 6.25 % quarterly installments through 23 Jul 2029. The option expires on 23 Jul 2035. After the transaction, Lee-Smith beneficially owns 2,746,261 derivative securities; no non-derivative share movement was disclosed.
The award strengthens management alignment over a four-year horizon, yet represents potential future dilution of roughly 2.75 million shares should the options be exercised.
On 07/23/2025, Accelerant Holdings (ARX) filed a Form 4 disclosing an initial grant of 209,515 stock options to newly appointed director Wendy Liisa Harrington.
- Exercise price: $21 per Class A common share.
- Vesting: 25 % cliff on 07/23/2026, then 6.25 % quarterly through 07/23/2029 (full vesting in four years), contingent on continuous service.
- Expiration: 07/23/2035 (10-year term).
- Post-transaction beneficial ownership: 209,515 derivative securities; no non-derivative share changes were reported.
The filing reflects a routine equity-compensation award meant to align director incentives with shareholder value. While the award represents potential future dilution, it is immaterial relative to ARX’s presumed outstanding share base and involves no cash outlay by the company today. No earnings data or other material corporate events were disclosed in this filing.